LEE011 succinate
98%
- Product Code: 54112
CAS:
1374639-75-4
Molecular Weight: | 552.63 g./mol | Molecular Formula: | C₂₇H₃₆N₈O₅ |
---|---|---|---|
EC Number: | MDL Number: | MFCD28167746 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature, stored under inert gas |
Product Description:
LEE011 succinate is primarily used in the treatment of certain types of cancer, particularly breast cancer. It functions as a cyclin-dependent kinase (CDK) inhibitor, specifically targeting CDK4 and CDK6, which play a crucial role in cell cycle regulation. By inhibiting these kinases, it helps to halt the proliferation of cancer cells, especially in hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer. It is often administered in combination with hormone therapy to enhance its efficacy. Additionally, ongoing research is exploring its potential in treating other cancers, such as lymphoma and solid tumors, due to its mechanism of action in disrupting cell cycle progression.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | White to yellow powder or crystals |
PURITY | 97.5-100 |
Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | ฿300.00 |
+
-
|
0.005 | 10-20 days | ฿510.00 |
+
-
|
0.010 | 10-20 days | ฿680.00 |
+
-
|
0.025 | 10-20 days | ฿880.00 |
+
-
|
0.100 | 10-20 days | ฿1,480.00 |
+
-
|
1.000 | 10-20 days | ฿5,460.00 |
+
-
|
LEE011 succinate
LEE011 succinate is primarily used in the treatment of certain types of cancer, particularly breast cancer. It functions as a cyclin-dependent kinase (CDK) inhibitor, specifically targeting CDK4 and CDK6, which play a crucial role in cell cycle regulation. By inhibiting these kinases, it helps to halt the proliferation of cancer cells, especially in hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer. It is often administered in combination with hormone therapy to enhance its efficacy. Additionally, ongoing research is exploring its potential in treating other cancers, such as lymphoma and solid tumors, due to its mechanism of action in disrupting cell cycle progression.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :